Pemazyre (pemigatinib tablets − Incyte) — Cigna
Myeloid/Lymphoid Neoplasms with eosinophilia and FGFR1 rearrangement
Initial criteria
- Patient age ≥ 18 years
- Patient has eosinophilia
- Cancer has fibroblast growth factor receptor 1 (FGFR1) rearrangement as detected by an approved test
Approval duration
1 year